readthroughSign in
CompanyGOSSNasdaqSan Diego, CA

Gossamer Bio, Inc.

Gossamer Bio develops seralutinib, a small molecule for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

10-QNov 16Latest SEC filing
Nov 10Latest story